LOGIN  |  REGISTER
Recursion
Amneal Pharmaceuticals

LevelJump Healthcare Sets Date for Requisitioned Shareholder Meeting

November 20, 2025 | Last Trade: C$0.05 0.00 0.00

Toronto, Ontario--(Newsfile Corp. - November 20, 2025) - Further to its news release of November 7, 2025, LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") announces that its board of directors (the "Board") has called an annual and special meeting of shareholders (the "Meeting") to be held on May 26th, 2026 in response to a shareholder requisition (the "Requisition") submitted by Frank Teti and Franmar Properties Ltd. (collectively the "Concerned Shareholders"). Under the Requisition, the Concerned Shareholders are asking LevelJump shareholders to vote on the removal of all Company directors and appointment of five new directors.

The Board, after consultation with its legal advisors, determined it is in the best interests of the Company to hold only one shareholder meeting to conduct the annual business of the Company and consider the matters set out in the Requisition. Among other considerations deliberated by the Board, this is the earliest date that audited financial statements will be available for shareholder consideration; moreover this represents prudent use of shareholder capital as it avoids the cost of holding both a separate special meeting and annual general meeting in close proximity to one another while still allowing the Company to address the matters set forth in the Requisition, especially given that a meeting of shareholders was just held in September 2025, less than 2 months ago.

Further details about the Meeting, the matters to be presented thereat, and how to vote will be made available to shareholders in advance of the Meeting, including in a management information circular to be mailed to shareholders of record as of the record date. Shareholders are not required to take any action at this time in respect of the Meeting.

The Board will continue to oversee the business in accordance with its fiduciary duties and remains available to engage with the Concerned Shareholders on any proposed plan that is in the best interests of all shareholders.

About LevelJump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

C4 Therapeutics

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page